Pauline Arias

Pauline Arias

Auto-generated profile, based on publicly available information

Pauline Arias

Department of Infectious Diseases, Reference Center for Tick-Borne Diseases, Paris and Northern Region, Intercommunal Hospital of Villeneuve-Saint-Georges, France

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2025 in Infectious Diseases Now
Verified
Journal Article
Closed access
ARAlice Raffetin
Alice Raffetin
FRF. Roblot
F. Roblot
LCLENORMAND Cédric
LENORMAND Cédric
YHY. Hansmann
Y. Hansmann
EBElisabeth Baux
Elisabeth Baux
KBK. Bouiller
K. Bouiller

28 November 2025 in Infectious Diseases Now
Verified
Journal Article
Closed access
EBElisabeth Baux
Elisabeth Baux
YHYves Hansmann
Yves Hansmann
CTChristine Tranchant
Christine Tranchant
FRFrance Roblot
France Roblot
PAPauline Arias
Pauline Arias
ARAlice Raffetin
Alice Raffetin

30 April 2025 in La Revue de Médecine Interne
Verified
Journal Article
Open access
VDValentin Dahdah
Valentin Dahdah
KCKevin Chevalier
Kevin Chevalier
PAPauline Arias
Pauline Arias
SSSamer Soliman
Samer Soliman
ARAlice Raffetin
Alice Raffetin
MKMohamed-Yacine Khitri
Mohamed-Yacine Khitri
Lyme borreliosis is suspected when there are compatible symptoms associated with tick exposure. The diagnosis, except for erythema migrans, is based on serology. However, in some cases, serology may be erroneous. A 50-year-old woman treated with obinutuzumab for a lymphoma presented with diffuse erythematous lesions, arthralgias and meningoradiculitis. Initial investigations, including multiple Lyme serologies, were inconclusive. After several hospitalizations, a next-generation sequencing analysis for infectious agents on cerebrospinal fluid was finally positive for Borrelia afzelii. Treatment with ceftriaxone resulted in complete resolution of symptoms. As anti-CD20 treatments are increasingly used in our internal medicine practices, it is important to keep a critical eye on the results of negative serologies in these situations. Direct tests (PCR, cultures, NGS, etc.) should therefore be preferred for diagnosing infections in patients on anti-CD20 therapy in case of a negative indirect test (serology). Furthermore, the absence of seroconversion seems to favor a more severe clinical picture in case of Lyme borreliosis (neurological symptoms), associated with rather rare manifestations (hepatitis, multiple erythema migrans).